EHI
RVMD icon

Eagle Health Investments’s Revolution Medicines RVMD Stock Holding History

Eagle Health Investments’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.5M Buy
120,346
+882
+0.7% +$129K 3.74% 12
2026
Q1 		$11.6M Buy
119,464
+3,564
+3% +$360K 2.03% 19
2025
Q4 		$9.23M Buy
+115,900
New +$7.6M 2.03% 17

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return
NNPTE
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne Warszawa, Poland $1.83B AUM 331.52% 1-Year Est. Return

Eagle Health Investments's RVMD Position: Q2 2026 in Review

Eagle Health Investments increased its Revolution Medicines (RVMD) stake by 0.74% in Q2 2026, buying an estimated $129K and bringing the position to 120,346 shares worth $22.5M. The position accounts for 3.74% of the portfolio, ranked #12.

Eagle Health Investments first reported a position in RVMD in Q4 2025 and has held it in 3 quarters since. 318 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Eagle Health Investments held 120,346 shares of Revolution Medicines worth $22.5M as of Q2 2026.
  • Eagle Health Investments bought 882 Revolution Medicines shares in Q2 2026, an estimated $129K.
  • Revolution Medicines made up 3.74% of Eagle Health Investments's portfolio in Q2 2026, its #12 holding.
  • Eagle Health Investments first reported a position in Revolution Medicines in Q4 2025 and has held it in 3 quarters since.
  • 318 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Eagle Health Investments's 13F filing for Q2 2026, filed 10 Aug 2026.